The legacy success of sildenafil has undeniably shaped the healthcare landscape. However, putting money in companies heavily dependent on biosimilars and the waning patent exclusivity surrounding this https://businessbookmark.com/story6953535/sildenafil-and-drugmakers-a-risky-investment